Analyst consensus rating
TELA Bio Analyst Rating: Buy
Direct answer
TELA Bio's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $2.10.
Forecast evidence checked September 12, 2026.
Get free TELA Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.97
- Average price target
- $2.10
- High price target
- $3.00
- Low price target
- $1.00
- Low target gap
- +3.1%
- Target upside
- +116.5%
- High target gap
- +209.3%
- Target range width
- 206.2%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- September 12, 2026
- Valid through
- September 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for TELA Bio?
TELA Bio has a verified Buy consensus. The same dataset has an average price target of $2.10.
How far are TELA Bio's low and high targets from the recorded price?
The low target implies +3.1%, while the high target implies +209.3%.
How many analysts are included in TELA Bio's consensus?
The verified consensus includes 5 analysts.
How is TELA Bio's target upside or downside calculated?
The average target of $2.10 is divided by the recorded price of $0.97, then one is subtracted to produce +116.5%. This does not guarantee a future return.
When was TELA Bio's analyst forecast verified?
The data was verified on 2026-09-12. The dataset is valid through 2026-09-19.